Diffuse Alveolar Hemorrhage in Acute Myeloid Leukemia

Area of Science:

• Pulmonary Medicine
• Hematology
• Oncology

Background:

• Diffuse alveolar hemorrhage (DAH) is a life-threatening syndrome.
• It commonly affects patients with hematological and nonhematological malignancies.

Observation:

• DAH presents with variable symptoms like dyspnea, fever, and cough.
• Hemoptysis is not always present, complicating diagnosis.
• Rapidly progressing hypoxia can lead to respiratory failure.

Findings:

• This case series highlights 5 patients with acute myeloid leukemia (AML) and DAH.
• It compares clinical manifestations, radiographic findings, treatment, and outcomes.
• DAH is more prevalent in hematological malignancies due to thrombocytopenia and immunosuppression.

Implications:

• Prompt diagnosis and treatment are vital for managing DAH in cancer patients.
• Understanding DAH pathophysiology aids in developing targeted therapies.
• This study emphasizes the importance of considering DAH in AML patients with respiratory symptoms.